New funding, both public and private, announced since the beginning of the year promises opportunities for laboratory instrument and product purchases. Last month, Paul Allen, cofounder of Microsoft, announced the formation of the $100 million Paul G. Allen Frontiers Group, designed to fund “out-of-the-box approaches” to bioscience research. Funding will be awarded through the Allen […]
Biotage Benefits from Currency Biotage fourth quarter 2015 sales grew 22.4%, 6.4% excluding currency, to SEK 168.5 million ($19.8 million = SEK 8.50 = $1). Gross margin improved 157 basis points to 56.0% of sales. Adjusted for a one-time write-down in the previous year, operating profit advanced 200 basis points to 12.0%. Currency also appreciably […]
IBO’s first report of 2016 for new laboratories outlines the construction and opening of labs in various sectors, including government, academia and biotechnology. On page 4, a table detailing the establishment of selected labs can be found, including new labs in the pharmaceutical industry. Government Various countries in Asia have broken ground on or approved […]
Currency fluctuations and economic turbulence not only produced a shift among IBO’s 2015 list of the top 30 analytical and life science instrument, aftermarket and lab product companies, but also yielded a calendar year sales decline when translated into US dollars. Total sales for the top 30 companies (see page 6) as reported in US […]
This month, the US Office of Science and Technology Policy released a report regarding research infrastructure and instrumentation funding for fiscal 2017. The information in the report is liable to change, as the fiscal 2017 budget has yet to be determined; however, the report also includes budget allocations for R&D facilities construction and research instrumentation […]
US equity markets steadily advanced in March with the Dow Jones Industrial Average, S&P 500 and NASDAQ improving 7.1%, 6.6% and 6.8%, respectively. Investors reacted favorably to US Federal Reserve Chair Janet Yellen’s dovish stance, as she advocated a more cautious approach to policy changes due to the fragile global economic environment. Consequently, the US […]
Following each Pittcon (see IBO 3/15/16), IBO details the new products introduced at the show. These are products that began shipping in winter 2015 or later. Part 1 of this article appeared in the March 15 issue. The list is not all inclusive. Atomic Spectroscopy Alpha Resources displayed a new elemental analyzer from Eltra, the […]
Although the use of 2D cellular assays for drug discovery predominates, the adoption of 3D assays is steadily growing. Three-dimensional assays (also known as 3D microtissues) are self-generated clusters of cell colonies. Such assays provide greater physiological and morphological relevance compared to 2D assays, aiming to reduce drug candidate failures and the use of animal […]
Every year, IBO selects three new products at Pittcon that standout among the many product introductions. These three products are distinguished by their innovation, commercial potential and advanced technology. This year’s top products feature capabilities that are the first of their kind. Hitachi High-Technologies’ AeroSurf 1500 SEM One of the drawbacks of EM is that […]
Each year, IBO compiles a list of new products on display or introduced at Pittcon. New products are generally defined as those that started shipping since winter 2015 or later. More new products will appear in the March 31 issue. The list is not all inclusive. Atomic Spectroscopy SciAps announced new versions of its Z […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
